Lebanon vs Türkiye: Treatment success rate for patients treated for MDR-TB
Lebanon
50.0%
in 2022
Türkiye
54.0%
in 2022
Lebanon rank
139th
Türkiye rank
136th
Treatment success rate for patients treated for MDR-TB over time
- Lebanon
- Türkiye
How they compare
Türkiye currently reports 54.0% against 50.0% in Lebanon, a difference of 4.0%.
That makes Türkiye's figure about 1.1 times Lebanon's.
The two have swapped places 9 times across 16 shared years of data; in 2007 it was Lebanon ahead.
Lebanon ranks 139th and Türkiye ranks 136th of 163 countries.
Across the 3 decades both report, Lebanon averaged higher in 1 and Türkiye in 2.
Head to head by decade
| Decade | Lebanon | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.7% | 66.3% | 10.7% | Türkiye |
| 2010s | 69.1% | 62.7% | 6.4% | Lebanon |
| 2020s | 50.0% | 50.7% | 0.7% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Lebanon or Türkiye?
- Türkiye, at 54.0% against 50.0% in Lebanon as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Lebanon and Türkiye?
- 4.0%, with Türkiye ahead.
- How many years of comparable data are there for Lebanon and Türkiye?
- 16 years are reported by both, from 2007 to 2022.
- How do Lebanon and Türkiye rank globally for treatment success rate for patients treated for mdr-tb?
- Lebanon ranks 139th and Türkiye ranks 136th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.